Financials data is unavailable for this security.
View more
Year on year Modern Chinese Medicine Group Co Ltd 's revenues fell -13.91% from 399.66m to 344.08m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 87.83m to 48.80m, a -44.44% decrease.
| Gross margin | 27.70% |
|---|---|
| Net profit margin | 5.97% |
| Operating margin | 10.28% |
| Return on assets | 2.88% |
|---|---|
| Return on equity | 3.12% |
| Return on investment | 3.08% |
More ▼
Cash flow in CNYView more
In 2023, Modern Chinese Medicine Group Co Ltd did not generate a significant amount of cash. However, the company earned 8.48m from its operations for a Cash Flow Margin of 2.46%. In addition the company used 4.19m on investing activities and also paid 326.00k in financing cash flows.
| Cash flow per share | 0.038 |
|---|---|
| Price/Cash flow per share | 8.30 |
| Book value per share | 0.8577 |
|---|---|
| Tangible book value per share | 0.8574 |
More ▼
Balance sheet in CNYView more
| Current ratio | 11.79 |
|---|---|
| Quick ratio | 10.90 |
| Total debt/total equity | 0.001 |
|---|---|
| Total debt/total capital | 0.001 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items dropped -44.44%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.41% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 0.00% |
| EPS growth(5 years) | 0.2303 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -78.07 |
More ▼
